China Serum Cancer Biomarkers Market Research Report 2016

November 2016 | 111 pages | ID: C269D09BEFDEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Serum Cancer Biomarkers

Revenue, means the sales value of Serum Cancer Biomarkers

This report studies Serum Cancer Biomarkers in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering

• Abbott Diagnostics
• Agilent Technologies
• Eli Lilly & Co.
• EUSA Pharma
• CytoCore, Inc.
• GE Healthcare
• Bruker Daltonics, Inc.
• Biomarker Technologies, LLC
• BioCurex, Inc.
• Asuragen, Inc.
• DiagnoCure, Inc.
• Beckman Coulter, Inc.

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by Application, this report focuses on consumption, market share and growth rate of Serum Cancer Biomarkers in each application, can be divided into

• Colorectal
• Prostate
• Lung
• Breast
• Ovarian

Contents

China Serum Cancer Biomarkers Market Research Report 2016

1 SERUM CANCER BIOMARKERS MARKET OVERVIEW

1.1 Product Overview and Scope of Serum Cancer Biomarkers
1.2 Serum Cancer Biomarkers Segment by Type
  1.2.1 China Production Market Share of Serum Cancer Biomarkers Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Applications of Serum Cancer Biomarkers
  1.3.1 Serum Cancer Biomarkers Consumption Market Share by Application in 2015
  1.3.2 Colorectal
  1.3.3 Prostate
  1.3.4 Lung
  1.3.5 Breast
  1.3.6 Ovarian
1.4 China Market Size (Value) of Serum Cancer Biomarkers (2011-2021)
1.5 China Serum Cancer BiomarkersStatus and Outlook
1.6 Government Policies

2 CHINA SERUM CANCER BIOMARKERS MARKET COMPETITION BY MANUFACTURERS

2.1 China Serum Cancer Biomarkers Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Serum Cancer Biomarkers Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Serum Cancer Biomarkers Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Serum Cancer Biomarkers Manufacturing Base Distribution, Sales Area, Product Type
2.5 Serum Cancer Biomarkers Market Competitive Situation and Trends
  2.5.1 Serum Cancer Biomarkers Market Concentration Rate
  2.5.2 Serum Cancer Biomarkers Market Share of Top 3 and Top 5 Manufacturers

3 CHINA SERUM CANCER BIOMARKERS MANUFACTURERS PROFILES/ANALYSIS

3.1 Abbott Diagnostics
  3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.1.2 Serum Cancer Biomarkers Product Type, Application and Specification
    3.1.2.1 Type I
    3.1.2.2 Type II
  3.1.3 Abbott Diagnostics Serum Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.1.4 Main Business/Business Overview
3.2 Agilent Technologies
  3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.2.2 111 Product Type, Application and Specification
    3.2.2.1 Type I
    3.2.2.2 Type II
  3.2.3 Agilent Technologies 111 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.2.4 Main Business/Business Overview
3.3 Eli Lilly & Co.
  3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.3.2 118 Product Type, Application and Specification
    3.3.2.1 Type I
    3.3.2.2 Type II
  3.3.3 Eli Lilly & Co. 118 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.3.4 Main Business/Business Overview
3.4 EUSA Pharma
  3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.4.2 Nov Product Type, Application and Specification
    3.4.2.1 Type I
    3.4.2.2 Type II
  3.4.3 EUSA Pharma Nov Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.4.4 Main Business/Business Overview
3.5 CytoCore, Inc.
  3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.5.2 Product Type, Application and Specification
    3.5.2.1 Type I
    3.5.2.2 Type II
  3.5.3 CytoCore, Inc. Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.5.4 Main Business/Business Overview
3.6 GE Healthcare
  3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.6.2 Million USD Product Type, Application and Specification
    3.6.2.1 Type I
    3.6.2.2 Type II
  3.6.3 GE Healthcare Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.6.4 Main Business/Business Overview
3.7 Bruker Daltonics, Inc.
  3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.7.2 Pharma & Healthcare Product Type, Application and Specification
    3.7.2.1 Type I
    3.7.2.2 Type II
  3.7.3 Bruker Daltonics, Inc. Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.7.4 Main Business/Business Overview
3.8 Biomarker Technologies, LLC
  3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.8.2 Product Type, Application and Specification
    3.8.2.1 Type I
    3.8.2.2 Type II
  3.8.3 Biomarker Technologies, LLC Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.8.4 Main Business/Business Overview
3.9 BioCurex, Inc.
  3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.9.2 Product Type, Application and Specification
    3.9.2.1 Type I
    3.9.2.2 Type II
  3.9.3 BioCurex, Inc. Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.9.4 Main Business/Business Overview
3.10 Asuragen, Inc.
  3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.10.2 Product Type, Application and Specification
    3.10.2.1 Type I
    3.10.2.2 Type II
  3.10.3 Asuragen, Inc. Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.10.4 Main Business/Business Overview
3.11 DiagnoCure, Inc.
3.12 Beckman Coulter, Inc.

4 CHINA SERUM CANCER BIOMARKERS CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2011-2016)

4.1 China Serum Cancer Biomarkers Capacity, Production and Growth (2011-2016)
4.2 China Serum Cancer Biomarkers Revenue and Growth (2011-2016)
4.3 China Serum Cancer Biomarkers Production, Consumption, Export and Import (2011-2016)

5 CHINA SERUM CANCER BIOMARKERS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Serum Cancer Biomarkers Production and Market Share by Type (2011-2016)
5.2 China Serum Cancer Biomarkers Revenue and Market Share by Type (2011-2016)
5.3 China Serum Cancer Biomarkers Price by Type (2011-2016)
5.4 China Serum Cancer Biomarkers Production Growth by Type (2011-2016)

6 CHINA SERUM CANCER BIOMARKERS MARKET ANALYSIS BY APPLICATION

6.1 China Serum Cancer Biomarkers Consumption and Market Share by Application (2011-2016)
6.2 China Serum Cancer Biomarkers Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Application
  6.3.2 Emerging Markets/Countries

7 SERUM CANCER BIOMARKERS MANUFACTURING COST ANALYSIS

7.1 Serum Cancer Biomarkers Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Serum Cancer Biomarkers

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Serum Cancer Biomarkers Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Serum Cancer Biomarkers Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA SERUM CANCER BIOMARKERS MARKET FORECAST (2016-2021)

11.1 China Serum Cancer Biomarkers Capacity, Production, Revenue Forecast (2016-2021)
11.2 China Serum Cancer Biomarkers Production, Import, Export and Consumption Forecast (2016-2021)
11.3 China Serum Cancer Biomarkers Production Forecast by Type (2016-2021)
11.4 China Serum Cancer Biomarkers Consumption Forecast by Application (2016-2021)
11.5 Serum Cancer Biomarkers Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Serum Cancer Biomarkers
Figure China Production Market Share of Serum Cancer Biomarkers by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Serum Cancer Biomarkers Consumption Market Share by Application in 2015
Figure Colorectal Examples
Figure Prostate Examples
Figure Lung Examples
Figure Breast Examples
Figure Ovarian Examples
Figure China Serum Cancer Biomarkers Revenue (Million USD) and Growth Rate (2011-2021)
Table China Serum Cancer Biomarkers Capacity of Key Manufacturers (2015 and 2016)
Table China Serum Cancer Biomarkers Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Serum Cancer Biomarkers Capacity of Key Manufacturers in 2015
Figure China Serum Cancer Biomarkers Capacity of Key Manufacturers in 2016
Table China Serum Cancer Biomarkers Production of Key Manufacturers (2015 and 2016)
Table China Serum Cancer Biomarkers Production Share by Manufacturers (2015 and 2016)
Figure 2015 Serum Cancer Biomarkers Production Share by Manufacturers
Figure 2016 Serum Cancer Biomarkers Production Share by Manufacturers
Table China Serum Cancer Biomarkers Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Serum Cancer Biomarkers Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Serum Cancer Biomarkers Revenue Share by Manufacturers
Table 2016 China Serum Cancer Biomarkers Revenue Share by Manufacturers
Table China Market Serum Cancer Biomarkers Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Serum Cancer Biomarkers Average Price of Key Manufacturers in 2015
Table Manufacturers Serum Cancer Biomarkers Manufacturing Base Distribution and Sales Area
Table Manufacturers Serum Cancer Biomarkers Product Type
Figure Serum Cancer Biomarkers Market Share of Top 3 Manufacturers
Figure Serum Cancer Biomarkers Market Share of Top 5 Manufacturers
Table Abbott Diagnostics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Diagnostics Serum Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Diagnostics Serum Cancer Biomarkers Market Share (2011-2016)
Table Agilent Technologies Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Agilent Technologies Serum Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Agilent Technologies Serum Cancer Biomarkers Market Share (2011-2016)
Table Eli Lilly & Co. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly & Co. Serum Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly & Co. Serum Cancer Biomarkers Market Share (2011-2016)
Table EUSA Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table EUSA Pharma Serum Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure EUSA Pharma Serum Cancer Biomarkers Market Share (2011-2016)
Table CytoCore, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CytoCore, Inc. Serum Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure CytoCore, Inc. Serum Cancer Biomarkers Market Share (2011-2016)
Table GE Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GE Healthcare Serum Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure GE Healthcare Serum Cancer Biomarkers Market Share (2011-2016)
Table Bruker Daltonics, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bruker Daltonics, Inc. Serum Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bruker Daltonics, Inc. Serum Cancer Biomarkers Market Share (2011-2016)
Table Biomarker Technologies, LLC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biomarker Technologies, LLC Serum Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Biomarker Technologies, LLC Serum Cancer Biomarkers Market Share (2011-2016)
Table BioCurex, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BioCurex, Inc. Serum Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure BioCurex, Inc. Serum Cancer Biomarkers Market Share (2011-2016)
Table Asuragen, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Asuragen, Inc. Serum Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Asuragen, Inc. Serum Cancer Biomarkers Market Share (2011-2016)
Table DiagnoCure, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table DiagnoCure, Inc. Serum Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure DiagnoCure, Inc. Serum Cancer Biomarkers Market Share (2011-2016)
Table Beckman Coulter, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Beckman Coulter, Inc. Serum Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Beckman Coulter, Inc. Serum Cancer Biomarkers Market Share (2011-2016)
Figure China Serum Cancer Biomarkers Capacity, Production and Growth (2011-2016)
Figure China Serum Cancer Biomarkers Revenue (Million USD) and Growth (2011-2016)
Table China Serum Cancer Biomarkers Production, Consumption, Export and Import (2011-2016)
Table China Serum Cancer Biomarkers Production by Type (2011-2016)
Table China Serum Cancer Biomarkers Production Share by Type (2011-2016)
Figure Production Market Share of Serum Cancer Biomarkers by Type (2011-2016)
Figure 2015 Production Market Share of Serum Cancer Biomarkers by Type
Table China Serum Cancer Biomarkers Revenue by Type (2011-2016)
Table China Serum Cancer Biomarkers Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Serum Cancer Biomarkers by Type (2011-2016)
Figure 2015 Revenue Market Share of Serum Cancer Biomarkers by Type
Table China Serum Cancer Biomarkers Price by Type (2011-2016)
Figure China Serum Cancer Biomarkers Production Growth by Type (2011-2016)
Table China Serum Cancer Biomarkers Consumption by Application (2011-2016)
Table China Serum Cancer Biomarkers Consumption Market Share by Application (2011-2016)
Figure China Serum Cancer Biomarkers Consumption Market Share by Application in 2015
Table China Serum Cancer Biomarkers Consumption Growth Rate by Application (2011-2016)
Figure China Serum Cancer Biomarkers Consumption Growth Rate by Application (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Serum Cancer Biomarkers
Figure Manufacturing Process Analysis of Serum Cancer Biomarkers
Figure Serum Cancer Biomarkers Industrial Chain Analysis
Table Raw Materials Sources of Serum Cancer Biomarkers Major Manufacturers in 2015
Table Major Buyers of Serum Cancer Biomarkers
Table Distributors/Traders List
Figure China Serum Cancer Biomarkers Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China Serum Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Table China Serum Cancer Biomarkers Production, Import, Export and Consumption Forecast (2016-2021)
Table China Serum Cancer Biomarkers Production Forecast by Type (2016-2021)
Table China Serum Cancer Biomarkers Consumption Forecast by Application (2016-2021)